TD Asset Management
NUVB icon

TD Asset Management’s Nuvation Bio NUVB Stock Holding History

TD Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,462
Closed -$131K – 1289
2026
Q1 		$131K Sell
30,462
-281,938
-90% -$1.57M ﹤0.01% 1225
2025
Q4 		$2.8M Buy
+312,400
New +$1.94M ﹤0.01% 910
2024
Q2 		– Sell
-154,200
Closed -$561K – 1407
2024
Q1 		$561K Buy
+154,200
New +$296K ﹤0.01% 1279
2023
Q4 		– Sell
-105,600
Closed -$142K – 1426
2023
Q3 		$142K Buy
105,600
+52,800
+100% +$87.9K ﹤0.01% 1381
2023
Q2 		$95K Hold
52,800
– – ﹤0.01% 1388
2023
Q1 		$87.6K Hold
52,800
– – ﹤0.01% 1403
2022
Q4 		$101K Hold
52,800
– – ﹤0.01% 1413
2022
Q3 		$115K Buy
+52,800
New +$151K ﹤0.01% 1424

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

TD Asset Management's NUVB Position: Q2 2026 in Review

TD Asset Management sold out of Nuvation Bio (NUVB) in Q2 2026, closing a stake of 30,462 shares — an estimated $131K sold.

TD Asset Management first reported a position in NUVB in Q3 2022 and held it in 8 quarters. The position peaked at $2.8M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • TD Asset Management reported no remaining Nuvation Bio position as of Q2 2026 after selling out during the quarter.
  • TD Asset Management sold 30,462 Nuvation Bio shares in Q2 2026, an estimated $131K.
  • TD Asset Management first reported a position in Nuvation Bio in Q3 2022 and held it in 8 quarters.
  • TD Asset Management's Nuvation Bio position peaked at $2.8M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.